LicianPro

SLS holders · CITADEL ADVISORS LLC 13F · SLS stock

CITADEL ADVISORS LLC Sellas Life Sciences Group Inc (SLS) 13F holding

CITADEL ADVISORS LLC reported 64,641 SLS shares valued at $273.4K as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest SLS 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the SLS holders table.

SLS reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-3164,641$273.4KCOM NEW
2025-09-30194,357$312.9KCOM NEW
2025-06-3084,993$186.1KCOM NEW

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.